Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Open House Drug Discount Agreements Leuprorelin, Atc L02ae02

Conclusion of Non-Exclusive Discount Agreements According to Section 130A Paragraph 8 Sgb V for the Active Ingredient Tafluprost | Timolol (Edp) - Taptiqom(R)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Natalizumab Ilo

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Budesonide (A07ea06)

Open House Original Discount Agreements 2023-25 ​​- Rilpivirine (Dosage Form: Film-Coated Tablets)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Allergen Extract from Birch Pollen (Itulazax(R))

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Dupilumab

Open House Drug Discount Contracts Fingolimod in the Potency 0.5 Mg, Atc L04aa27

Conclusion of Non-Exclusive Discount Agreements According to Section 130A Paragraph 8 Sgb V for the Active Ingredient Glecaprevir | Pibrentasvir

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Tafluprost (Edp)